Allied Market Research

2024

Arthritic Therapeutic Market

Arthritic Therapeutic Market Size, Share, Competitive Landscape and Trend Analysis Report by Type (Biologics, Non-biologics) and by Application (Rheumatoid Arthritis, Osteoarthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Fibromyalgia, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Arthritis is the inflammation of one or more joints, frequently accompanied by pain. There are several types of arthritis, which includes those related to wear & tear of cartilage (osteoarthritis) and that caused by an overactive immune system (rheumatoid arthritis).

The global arthritic therapeutic market growth is driven by increase in incidence of autoimmune disorders, rise in geriatric population, newer drugs in pipeline, surge in adoption rates of anti-arthritic drugs, increase in the use of anti-inflammatory therapeutics, and proactive government initiatives. However, the side effects associated with these drugs, such as serious infections, edema, ulcers; and patent expiration of certain drugs, restrain the market growth. In addition, increase in healthcare expenses and public awareness is expected to provide several opportunities for the market growth.

The global arthritic therapeutic market is segmented on the basis of type, application, and geography. On the basis of type, it is bifurcated into biologics and non-biologics. Based on application, it is categorized into rheumatoid arthritis, osteoarthritis, osteoporosis, psoriatic arthritis, ankylosing spondylitis, and fibromyalgia. Geographically, it is analyzed across four regions, namely, North America, Europe, Asia-Pacific, and LAMEA.

The key companies operating in the market include AbbVie Inc., Merck & Co., Inc., Novartis AG, AstraZeneca, Abbott Laboratories, Amgen Limited & Amgen Ireland Limited, Baxter, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Johnson & Johnson, GlaxoSmithKline plc., Celgene Corporation, and Pfizer Inc.

Key Benefits

  • Comprehensive analysis of the industry along with competitive rivalry is provided in the report.
  • In depth analysis to the current trends and future projections have been provided for the to understand the financial appetency of the market.
  • The drivers, restraints, and potential opportunities in the industry along with their impact analyses have been provided in the report.
  • Comprehensive analysis of the various factors that drive and restrain the growth of this market is provided.
  • Extensive analysis of the key market players and their strategies is provided in the report.

Arthritic Therapeutic Market Report Highlights

Aspects Details
Arthritic Therapeutic Market By Type
By Type
  • Biologics
    • Gene Therapy
    • Recombinant Proteins
    • Enzymes
  • Non-biologics
    • Non-steroidal Anti-inflammatory Drugs (NSAIDs)
    • Disease Modified Anti-rheumatoid Drugs (DMARDs)
    • Steroids
Arthritic Therapeutic Market By Application
By Application
  • Rheumatoid Arthritis
  • Osteoarthritis
  • Psoriatic Arthritis
  • Ankylosing Spondylitis
  • Fibromyalgia
  • Others
Arthritic Therapeutic Market By Region
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players
Key Market Players

Eli Lilly and Company, Novartis AG, Merck & Co., Inc., Amgen Limited & Amgen Ireland Limited, AbbVie Inc., AstraZeneca, Celgene Corporation, GlaxoSmithKline plc., F. Hoffmann-La Roche Ltd., Abbott Laboratories, Baxter, Bristol-Myers Squibb Company, Johnson & Johnson, Pfizer Inc.

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Arthritic Therapeutic Market

Global Opportunity Analysis and Industry Forecast, 2023-2032